Welcome to LookChem.com Sign In|Join Free
  • or


Post Buying Request

850649-62-6 Suppliers

Recommended suppliersmore

Product FOB Price Min.Order Supply Ability Supplier
Alogliptin benzoate
Cas No: 850649-62-6
No Data 1 Gram 1 Metric Ton/Year Hefei Lifeon Pharmaceutical Co., Ltd. Contact Supplier
Alogliptin high purity, lowest price in China
Cas No: 850649-62-6
No Data 1 Kilogram 3 Metric Ton/Month CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD Contact Supplier
Alogliptin benzoate
Cas No: 850649-62-6
No Data 25 Kilogram Metric Ton/Day HANGZHOU CLAKE BIOTECH CO.,LTD Contact Supplier
Alogliptin benzoate 99.0% Alogliptin Monobenzoate GMP Certificate CAS No.850649-62-6
Cas No: 850649-62-6
No Data 10 Gram 1000 Kilogram/Month Henan Surface Industry Co Ltd Contact Supplier
Alogliptin CAS 850649-62-6
Cas No: 850649-62-6
No Data 10 Gram 500 Kilogram/Month Hangzhou Hysen Pharma co.,Ltd. Contact Supplier
Alogliptin Benzoate
Cas No: 850649-62-6
No Data No Data No Data Koning Pharmchem Co., Ltd. Contact Supplier
Alogliptin benzoate
Cas No: 850649-62-6
USD $ 1.0-2.0 / Metric Ton 1 Metric Ton 100 Metric Ton/Week Hebei yanxi chemical co.,LTD. Contact Supplier
High purity 850649-62-6 Alogliptin Benzoate
Cas No: 850649-62-6
USD $ 100.0-500.0 / Gram 1 Gram 99999 Gram/Year Hangzhou Dingyan Chem Co., Ltd Contact Supplier
High quality Alogliptin benzoate Cas 850649-62-6 with best price and good service
Cas No: 850649-62-6
No Data 1 Kilogram 5 Metric Ton/Year Wuhan Fortuna Chemical Co.,Ltd Contact Supplier
Fresh In Stock:SYR 322; with BEST PRICE
Cas No: 850649-62-6
USD $ 1.0-1.0 / Metric Ton 1 Metric Ton 1000 Metric Ton/Day Scale Chemical Corporation Contact Supplier

850649-62-6 Usage

Indications and Usage

Alogliptin (benzoic acid) is a type-2 diabetes medication, and it is a type of serine protease dipeptidyl peptidase IV (DPP-4) inhibitor developed by the Japanese company Takeda. Alogliptin, used alone or in combination with other blood sugar-lowering medication, is usually well-tolerated in type-2 diabetes patients. This medication has a low risk of hypoglycemia, with Alogliptin treatment groups ≤8.3% and placebo groups ≤10.5%, and shows no difference between young and elderly patients. In addition to effectively lowering blood sugar, this medicine also lowers the risks of hypoglycemia and weight increase, overcoming great obstacles in patient treatment and providing new hope for diabetes treatment.


ChEBI: A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes.

Adverse reactions

Common side effects of Alogliptin include nasopharyngitis, headaches, and upper respiratory tract infection. Most side effects are light to moderate and are unrelated to dosage.

Mechanisms of Action

Alogliptin selectively inhibits DPP-4 to reduce the inactivation of glucagon-like peptide 1 (GLP-1) and increase the GLP-1 levels in the body, thus lowering blood sugar. Once blood sugar reaches normal levels, it will cease its sugar-lowering effects, thus effectively reducing the risks of hypoglycemia. Additionally, DPP-4 inhibitor also slows gastric emptying, increases the feeling of fullness, and controls appetite, thus helping patients control their weight.


Treatment of type 2 diabetes.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017


1.1 GHS Product identifier

Product name alogliptin benzoate

1.2 Other means of identification

Product number -
Other names Vipidia (TN)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:850649-62-6 SDS

Please post your buying leads,so that our qualified suppliers will soon contact you!

*Required Fields